Abstract
Ganoderma (Lingzhi) has been used as a medicinal mushroom to promote health in China for more than 2000 years. The modern research and development of Ganoderma industry started from the 1950s, in which the successful cultivation of Ganoderma fruiting body and submerged fermentation of Ganoderma mycelium lay the critical foundation for the industry development. Recent decades have witnessed the rapid development of Ganoderma industry, which is boosted through various efforts made by the government, the academia, and the industry. In this chapter, the development of Ganoderma industry in China is reviewed in terms of gross output, standards, scientific articles, patents, and associations. In addition, development of Ganoderma products and manufacturing technologies are also overviewed and summarized. In the last section, several innovation trends are suggested for the further development of Ganoderma industry.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Lin ZB (2015) Chapter 1: historical data of Chinese Ganoderma (Lingzhi) research. In: Lin ZB (ed) Modern research on Ganoderma (Lingzhi), 4th edn. Peking University Medical Press, Beijing, pp 1–7
He BW, Xu DL, Ma L, Chen HJ (2016) Development and safety manufacturing of Ganoderma industry in Zhejiang. Edible Med Mushroom 24(6):353–357
Lin ZB (1979) Current situation of Ganoderma research in China. Acta Pharm Sin 14(3):183–192
Liu XM, Liu FP, Lin YH, Xu WJ (1991) Application of Ganoderma in drugs and supplements. Sub Trop Plant Sci 20(02):48–50
Lin ZB (2015) Chapter 4: cut-log cultivation of Ganoderma (Lingzhi). In: Lin ZB (ed) Modern research on Ganoderma (Lingzhi), 4th edn. Peking University Medical Press, Beijing, pp 56–73
Li MY (2015) Research and development of quality standard and specifications of Ganoderma lucidum from an industry chain perspective. Edible Med Mushroom 23(5):276–279
ISO 21315 (2018) Traditional Chinese medicine—Ganoderma lucidum fruiting body. International Organization for Standardization
Sanodiya BS, Thakur GS, Baghel RK, Prasad GBKS, Bisen PS (2009) Ganoderma lucidum: a potent pharmacological macrofungus. Curr Pharm Biotechnol 10(8):717–742
Paterson RRM (2006) Ganoderma–a therapeutic fungal biofactory. Phytochemistry 67(18):1985–2001
Bishop KS, Kao CH, Xu Y, Glucina MP, Paterson RRM, Ferguson LR (2015) From 2000 years of Ganoderma lucidum to recent developments in nutraceuticals. Phytochemistry 114:56–65
Hsu KD, Cheng KC (2018) From nutraceutical to clinical trial: frontiers in Ganoderma development. Appl Microbiol Biotechnol 102(21):9037–9051
Chen ZQ, Huang WL, Jin X, Liu ZM, Huang YJ, Li P, Zheng LY (2016) Research progress on Ganoderma lucidum intensive processing in China. J Food Saf Qual 7(2):639–644
Lawrence XY, Ilgaz A, Barbara A, Gregory A, Tara GB, Ashley B, Margaret C, David D, Joseph F, Adam CF, Scott F, Brian H, Henry H, Stephen WH, Robert I, Bruce DJ, Robert J, Paula K, Emanuela L, Sau LL, Richard L, Grace M, Mehul M, Ganapathy M, Moheb N, Roger N, Mary O, Thomas OC, Jim P, Raju GK, Mahesh R, Giuseppe R, Susan R, Anna S, Arzu S, Paul S, Vinod S, Ramesh S, Michael PT, Tony T, Bernhardt LT, Katherine T, Siva V, Martin VT, Fionnuala W, Russell W, Janet W, Geoffrey W, Larisa W, Louis Y, Diane Z (2015) Advancing product quality: a summary of the inaugural FDA/PQRI conference. AAPS J 18(2):528–543
Gou JH, Li MY (2013) Research of the operational mode of the agriculture-related whole industrial chain based on food safety: take Zhejiang Longevity Valley as an example. J Zhejiang Int Stud Univ 2(2):86–92
Kumar MNR (2000) A review of chitin and chitosan applications. React Funct Polym 46(1):1–27
Hayes M, Carney B, Slater J, Brück W (2008) Mining marine shellfish wastes for bioactive molecules: chitin and chitosan–part B: applications. Biotechnol J 3(7):878–889
Chen CC, Cheh LW, Yang JC, Tsai CM, Keh ES, Sheu MT, SU CH, Hong HH, Lin CT, Lee SY (2007) Non-shellfish chitosan from the fruiting body residue of Ganoderma tsugae for long-lasting antibacterial guided-tissue regeneration barriers. J Dent Sci 2(1):19–29
Su CH, Sun CS, Juan SW, Hu CH, Ke WT, Sheu MT (1997) Fungal mycelia as the source of chitin and polysaccharides and their applications as skin substitutes [J]. Biomaterials 18(17):1169–1174
Cheng YY, Qu HB, Zhang BL (2016) Chinese medicine industry 4.0: advancing digital pharmaceutical manufacture toward intelligent pharmaceutical manufacture. Chin J Chin Mater Med 41(1):1–5
Ferreira IC, Heleno SA, Reis FS, Stojkovic D, Queiroz MJ, Vasconcelos MH, Sokovic M (2015) Chemical features of Ganoderma polysaccharides with antioxidant, antitumor and antimicrobial activities. Phytochemistry 114:38–55
Cör D, Knez Ž, Knez Hrnčič M (2018) Antitumour, antimicrobial, antioxidant and antiacetylcholinesterase effect of Ganoderma lucidum terpenoids and polysaccharides: a review. Molecules 23(3):649
Ahmad MF (2018) Ganoderma lucidum: persuasive biologically active constituents and their health endorsement. Biomed Pharmacother 107:507–519
Nie S, Zhang H, Li W, Xie M (2013) Current development of polysaccharides from Ganoderma: isolation, structure and bioactivities. Bioact Carbohydr Diet Fibre 1(1):10–17
Zhang M, Cui SW, Cheung PCK, Wang Q (2007) Antitumor polysaccharides from mushrooms: a review on their isolation process, structural characteristics and antitumor activity. Trends Food Sci Technol 18(1):4–19
Li XL, Zhou AG, Li XM (2007) Inhibition of Lycium barbarum polysaccharides and Ganoderma lucidum polysaccharides against oxidative injury induced by radiation in rat liver mitochondria. Carbohydr Polym 69(1):172–178
Jiang H, Sun P, He J, Shao P (2012) Rapid purification of polysaccharides using novel radial flow ion-exchange by response surface methodology from Ganoderma lucidum. Food Bioprod Process 90(1):1–8
Xia Q, Zhang H, Sun X, Zhao H, Wu L, Zhu D, Yang G, Shao Y, Zhang X, Mao X, Zhang L, She G (2014) A comprehensive review of the structure elucidation and biological activity of triterpenoids from Ganoderma spp. Molecules 19(11):17478–17535
Li Y, Zhu ZM, Yao WX, Chen RY (2012) Study progress on triterpenoids from Ganoderma Lucidum. Chin J Chin Mater Med 37(2):165–171
Li L, Guo HJ, Zhu LY, Zheng L, Liu X (2016) A supercritical-CO2 extract of Ganoderma lucidum spores inhibits cholangiocarcinoma cell migration by reversing the epithelial–mesenchymal transition. Phytomedicine 23(5):491–497
Cheng YY, Qian ZZ, Zhang BL (2017) A strategy of constructing the technological system for quality control of Chinese medicine based on process control and management. Chin J Chin Mater Med 42(1):1–5
Newman DJ, Cragg GM (2016) Natural products as sources of new drugs from 1981 to 2014. J Nat Prod 79(3):629–661
Cao Y, Xu X, Liu S, Huang L, Gu J (2018) A cancer immunotherapy review. Front Pharmacol 9:1217
Lin TY, Hsu HY (2016) Ling Zhi-8 reduces lung cancer mobility and metastasis through disruption of focal adhesion and induction of MDM2-mediated Slug degradation. Cancer Lett 375(2):340–348
Lin TY, Hsu HY, Sun WH, Wu TH, Tsao SM (2017) Induction of Cbl-dependent epidermal growth factor receptor degradation in Ling Zhi-8 suppressed lung cancer. Int J Cancer 140:2596–2607
Wang K, Bao L, Ma K, Zhang J, Chen B, Han J, Ren JW, Luo HJ, Liu HW (2016) A novel class of α-glucosidase and HMG-CoA reductase inhibitors from Ganoderma leucocontextum and the anti-diabetic properties of ganomycin i in kk-ay mice. Eur J Med Chem 127:1035–1046
Wang K, Bao L, Zhou N, Zhang J, Liao M, Zheng Z, Wang Y, Liu C, Wang J, Wang L, Wang W, Liu S, Liu H (2018) Structural modification of natural product ganomycin I leading to discovery of a α-glucosidase and HMG-CoA reductase dual inhibitor improving obesity and metabolic dysfunction in vivo. J Med Chem 61(8):3609–3625
Su L, Liu L, Jia Y, Lei L, Liu J, Zhu S, Zhou H, Chen R, Lu HAJ, Yang B (2017) Ganoderma triterpenes retard renal cyst development by downregulating Ras/MAPK signaling and promoting cell differentiation. Kidney Int 92(6):1404–1418
Li X, Zhang JA, Huang J, Ma AQ, Yang JF, Li WM, Wu Z, Yao C, Zhang Y, Yao W, Zhang B, Gao R, Efficacy and Safety of Qili Qiangxin Capsules for Chronic Heart Failure Study Group (2013) A multicenter, randomized, double-blind, parallel-group, placebo-controlled study of the effects of qili qiangxin capsules in patients with chronic heart failure. J Am Coll Cardiol 62(12):1065–1072
Wang S, Hu Y, Tan W, Wu X, Chen R, Cao J, Chen M, Wang Y (2012) Compatibility art of traditional Chinese medicine: from the perspective of herb pairs. J Ethnopharmacol 143(2):412–423
Wang Y, Fan X, Qu H, Gao X, Cheng Y (2012) Strategies and techniques for multi-component drug design from medicinal herbs and traditional Chinese medicine. Curr Top Med Chem 12(12):1356–1362
Thomas DW, Burns J, Audette J, Carroll A, Dow-Hygelund C, Hay M (2016) Clinical development success rates 2006–2015. Biomedtracker/BIO/Bend/Amplion, San Diego/Washington, DC
Lee SL, Dou JH, Agarwal R, Temple R, Beitz J, Wu C, Mulberg A, Yu LX, Woodcock J (2015) Evolution of traditional medicines to botanical drugs. Science 347(6219):S32–S34
Wang RL (2018) Analysis of registration for new Chinese herbal drug from 2011-2017. Mod Chin Med 20(7):910–914
Schmuff NR, Lin DT (2008) Chemistry, manufacturing and controls (CMC). In: Wiley encyclopedia of clinical trials. Wiley, Manhattan
Zanella F, Lorens JB, Link W (2010) High content screening: seeing is believing. Trends Biotechnol 28(5):237–245
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer Nature Singapore Pte Ltd.
About this chapter
Cite this chapter
Li, Z., Zhou, J., Lin, Z. (2019). Development and Innovation of Ganoderma Industry and Products in China. In: Lin, Z., Yang, B. (eds) Ganoderma and Health. Advances in Experimental Medicine and Biology, vol 1181. Springer, Singapore. https://doi.org/10.1007/978-981-13-9867-4_7
Download citation
DOI: https://doi.org/10.1007/978-981-13-9867-4_7
Published:
Publisher Name: Springer, Singapore
Print ISBN: 978-981-13-9866-7
Online ISBN: 978-981-13-9867-4
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)